PCUR
19 Apr 2022
PELLFICURE
NCT03137758
A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Pellficure Pharmaceuticals, Inc
Cancer Type | Prostate |
---|---|
Trial Type | Treatment |
Phase | Phase I |
Age Range | 18 years and older |
Sex | Male |
Tumour Stream | - |
Cancer Stage | Metastatic or Widespread |
Anticipated Start Date | 2017-07-24 |
Anticipated End Date | 2019-09-17 |
Hospital | Cancer Research SA |
---|---|
Clinical Trial Coordinator | Kelly Mead |
admin@cancerresearchsa.com.au | |
Phone | 08 8359 2565 |
Principal Investigator | Dr Sarwan Bishnoi |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs